The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury
Allan Tsung, Michael T. Stang, Atsushi Ikeda, Nathan D. Critchlow, Kunihiko Izuishi, Atsunori Nakao, Meagan H. Chan, Geetha Jeyabalan, John H. Yim, David A. Geller
Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH 2-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-α, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-γ and IFN-β were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-α and IL-1β also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.
G1261-G1268
American Journal of Physiology - Gastrointestinal and Liver Physiology
https://doi.org/10.1152/ajpgi.00460.2005
Hepatic ischemia
Inducible nitric oxide synthase
Liver injury
c-Jun NH-terminal kinase
10.1152/ajpgi.00460.2005
Fingerprint Dive into the research topics of 'The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury'. Together they form a unique fingerprint.
Interferon Regulatory Factor-1 Medicine & Life Sciences
Reperfusion Injury Medicine & Life Sciences
Liver Medicine & Life Sciences
Knockout Mice Medicine & Life Sciences
Nitric Oxide Synthase Type II Medicine & Life Sciences
Tsung, A., Stang, M. T., Ikeda, A., Critchlow, N. D., Izuishi, K., Nakao, A., Chan, M. H., Jeyabalan, G., Yim, J. H., & Geller, D. A. (2006). The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. American Journal of Physiology - Gastrointestinal and Liver Physiology, 290(6), G1261-G1268. https://doi.org/10.1152/ajpgi.00460.2005
The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. / Tsung, Allan; Stang, Michael T.; Ikeda, Atsushi; Critchlow, Nathan D.; Izuishi, Kunihiko; Nakao, Atsunori; Chan, Meagan H.; Jeyabalan, Geetha; Yim, John H.; Geller, David A.
In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 290, No. 6, 06.2006, p. G1261-G1268.
Tsung, A, Stang, MT, Ikeda, A, Critchlow, ND, Izuishi, K, Nakao, A, Chan, MH, Jeyabalan, G, Yim, JH & Geller, DA 2006, 'The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1261-G1268. https://doi.org/10.1152/ajpgi.00460.2005
Tsung A, Stang MT, Ikeda A, Critchlow ND, Izuishi K, Nakao A et al. The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. American Journal of Physiology - Gastrointestinal and Liver Physiology. 2006 Jun;290(6):G1261-G1268. https://doi.org/10.1152/ajpgi.00460.2005
Tsung, Allan ; Stang, Michael T. ; Ikeda, Atsushi ; Critchlow, Nathan D. ; Izuishi, Kunihiko ; Nakao, Atsunori ; Chan, Meagan H. ; Jeyabalan, Geetha ; Yim, John H. ; Geller, David A. / The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2006 ; Vol. 290, No. 6. pp. G1261-G1268.
@article{9ea5debb90de41df8b6dc6cca1c123ea,
title = "The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury",
abstract = "Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH 2-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-α, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-γ and IFN-β were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-α and IL-1β also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.",
keywords = "Cytokines, Hepatic ischemia, Inducible nitric oxide synthase, Liver injury, c-Jun NH-terminal kinase",
author = "Allan Tsung and Stang, {Michael T.} and Atsushi Ikeda and Critchlow, {Nathan D.} and Kunihiko Izuishi and Atsunori Nakao and Chan, {Meagan H.} and Geetha Jeyabalan and Yim, {John H.} and Geller, {David A.}",
doi = "10.1152/ajpgi.00460.2005",
pages = "G1261--G1268",
journal = "American Journal of Physiology - Gastrointestinal and Liver Physiology",
T1 - The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury
AU - Tsung, Allan
AU - Stang, Michael T.
AU - Ikeda, Atsushi
AU - Critchlow, Nathan D.
AU - Izuishi, Kunihiko
AU - Nakao, Atsunori
AU - Chan, Meagan H.
AU - Jeyabalan, Geetha
AU - Yim, John H.
AU - Geller, David A.
N2 - Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH 2-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-α, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-γ and IFN-β were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-α and IL-1β also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.
AB - Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH 2-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-α, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-γ and IFN-β were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-α and IL-1β also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.
KW - Cytokines
KW - Hepatic ischemia
KW - Inducible nitric oxide synthase
KW - Liver injury
KW - c-Jun NH-terminal kinase
U2 - 10.1152/ajpgi.00460.2005
DO - 10.1152/ajpgi.00460.2005
SP - G1261-G1268
JO - American Journal of Physiology - Gastrointestinal and Liver Physiology
JF - American Journal of Physiology - Gastrointestinal and Liver Physiology